Floatz logo

PYRIDOXAL ISONICOTINOYL HYDRAZONE

Anemia (Iron-Loading)

Case Western Reserve UniversitySmall moleculePhase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Anemia (Iron-Loading) cohort.

Asset / SponsorPhaseRating
DESFERRIOXAMINE B
National Heart, Lung, and Blood Institute (NHLBI)
Phase 2B

Same molecule, other indications

PYRIDOXAL ISONICOTINOYL HYDRAZONE is also rated in:

Beta-ThalassemiaDormant
CCC
Indicative ·
55 / 100
View asset →
Hematologic DiseasesDormant
CCC
Indicative ·
55 / 100
View asset →
HemoglobinopathiesDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →